3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other solid neoplasm
1
Gastrointestinal
1
CNS
1
Conditions
Neoplasms
1
Interventions
Radiotherapy
9
Drug Therapy
9
Cisplatin
9
Gemcitabine
8
Docetaxel
7
Carboplatin
7
Blood Specimen Collection
7
Nivolumab
6
Fluorouracil
6
Pemetrexed
5
Capecitabine
5
pembrolizumab
4
Surveys and Questionnaires
4
Positron Emission Tomography Computed Tomography
4
Paclitaxel
4
Oxaliplatin
4
Exercise
4
Everolimus
4
Data Collection
4
Cetuximab
4
indibulin
3
icotinib
3
Vincristine
3
Trastuzumab
3
Standard of Care
3
Radiosurgery
3
Neoadjuvant Therapy
3
Magnetic Resonance Spectroscopy
3
Interleukin-2
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
vandetanib
×
Tumor-Agnostic
×
Clear all
NCT02530411
2015-08-21
FURVA
Velindre NHS Trust
Phase 2
Unknown
160 enrolled